Bank of America’s Climb Bio, Inc. Common Stock CLYM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.46K | Sell |
7,627
-29,660
| -80% | -$36.8K | ﹤0.01% | 6179 |
|
|
2025
Q1 | $45.5K | Sell |
37,287
-996,405
| -96% | -$1.22M | ﹤0.01% | 5768 |
|
|
2024
Q4 | $1.86M | Buy |
1,033,692
+1,016,323
| +5,851% | +$1.83M | ﹤0.01% | 3800 |
|
|
2024
Q3 | $88.4K | Buy |
17,369
+8,122
| +88% | +$41.3K | ﹤0.01% | 5495 |
|
|
2024
Q2 | $65.7K | Buy |
+9,247
| New | +$65.7K | ﹤0.01% | 5588 |
|
|
2024
Q1 | – | Sell |
-3
| Closed | -$8 | – | 7108 |
|
|
2023
Q4 | $8 | Sell |
3
-1,387
| -100% | -$3.7K | ﹤0.01% | 6849 |
|
|
2023
Q3 | $3.66K | Buy |
1,390
+471
| +51% | +$1.24K | ﹤0.01% | 6132 |
|
|
2023
Q2 | $2.57K | Buy |
919
+224
| +32% | +$627 | ﹤0.01% | 6216 |
|
|
2023
Q1 | $2.02K | Sell |
695
-4
| -0.6% | -$12 | ﹤0.01% | 6384 |
|
|
2022
Q4 | $2.57K | Buy |
699
+3
| +0.4% | +$11 | ﹤0.01% | 6362 |
|
|
2022
Q3 | $2K | Sell |
696
-2,688
| -79% | -$7.72K | ﹤0.01% | 6716 |
|
|
2022
Q2 | $10K | Buy |
3,384
+1,845
| +120% | +$5.45K | ﹤0.01% | 6573 |
|
|
2022
Q1 | $13K | Sell |
1,539
-2,760
| -64% | -$23.3K | ﹤0.01% | 6857 |
|
|
2021
Q4 | $45K | Buy |
4,299
+3,685
| +600% | +$38.6K | ﹤0.01% | 6410 |
|
|
2021
Q3 | $11K | Buy |
+614
| New | +$11K | ﹤0.01% | 6648 |
|